Yunnan Baiyao Group (000538) Stock Price, Fundamentals & Analysis

What 000538 does

Yunnan Baiyao Group (000538) is a Healthcare stock listed on the Shenzhen Stock Exchange in the Drug Manufacturers – Specialty & Generic industry. The company sells pharmaceuticals, medicinal materials, health and daily chemical products in China. Its best-known offerings include the Yunnan Baiyao aerosol, ointment, and band-aid, along with generic drugs and natural specialty medicines covering areas such as physical fitness, respiratory ailments, cardiovascular health, gynecology, and pediatrics. The company also provides medical devices, tea products, and pharmaceutical supply chain service solutions. Founded in 1902 and headquartered in Kunming, China, Yunnan Baiyao Group employs 9,286 people. It is part of the Shenzhen Stock Exchange stocks directory and can be compared with peers such as Chongqing Zhifei Biological Products (300122), Huadong Medicine (000963), and Walvax Biotechnology (300142).

Key numbers explained

• Price: 49.87 CNY is the latest trading price of one share of Yunnan Baiyao Group on the Shenzhen Stock Exchange.
• Market capitalization: 88.98B CNY represents the total market value of all outstanding shares, calculated as share price multiplied by the number of shares.
• P/E ratio: The trailing P/E ratio of 17.1 shows how much investors pay per CNY of earnings; the forward P/E ratio of 15.4 uses expected future earnings.
• Dividend yield: The dividendYield of 3.17% indicates the annual dividend as a percentage of the current share price.
• Payout ratio: 54% of earnings are paid out as dividends, meaning the company retains the remainder for reinvestment or other corporate purposes.
• Beta: A beta of 0.09 suggests the stock's price movements have historically been much less volatile than the overall market.
• 52-week range: The lowest and highest price in the last 52 weeks was 46.29 – 58.2, showing the trading range over the past year.
• Revenue: Trailing 12-month revenue of 41.81 mld. CNY reflects the total value of goods and services sold, with a year-over-year growth of -1.3%.

What to watch

• Yunnan Baiyao Group operates in the Healthcare sector, where regulatory changes, drug approval cycles, and public health trends can affect demand.
• The company's reliance on a mix of traditional Chinese medicine products and generic drugs means competitive dynamics and pricing pressure in the pharmaceutical industry are relevant factors.
• A dividendYield of 3.17% and a 54% payout ratio may attract income-focused investors, but the sustainability of dividends depends on ongoing earnings and cash flow.
• The low beta of 0.09 suggests defensive characteristics, though it also means the stock may lag during broad market rallies.
• Revenue growth of -1.3% and a trailing P/E ratio of 17.1 are inputs that investors typically monitor alongside industry peers such as Chang Chun High and New Technology Industry (Group) (000661) and Shijiazhuang Yiling Pharmaceutical (002603).